Stock Market News2 months BMY or VRTX: Which Is the Better Value Stock Right Now? Zacks
BMY vs. VRTX: Which Stock Is the Better Value Option?
Bristol · Bristol-Myers Squibb (BMY) · Pharmaceuticals · Vertex (VRTX)
X9 hours Vertex Pharmaceuticals (VRTX) Gains But Lags Market: What You Should Know Zacks
X12 hours Top Stock Reports for T-Mobile, Toyota Motor & Vertex Pharmaceuticals Zacks
X16 hours BMY Gets EC Nod for Opdivo Plus Yervoy in First-Line Colorectal Cancer Zacks
X2 days Vertex Secures FDA Approval for New Cystic Fibrosis Drug Alyftrek Zacks
X2 days Jazz Pharmaceuticals: Should Sing A Better Tune In 2025 Seeking Alpha
X2 days Enanta Pharmaceuticals (ENTA) Moves 7.2% Higher: Will This Strength Last? Zacks
X2 days Ionis Pharmaceuticals: Promising Growth From Tryngolza Approval Seeking Alpha
X2 days Should You Invest in the iShares U.S. Pharmaceuticals ETF (IHE)? Zacks
X4 days Is Recursion Pharmaceuticals Stock a Millionaire Maker? Yahoo Finance
X4 days Vertex Pharmaceuticals price target lowered to $441 from $506 at Bernstein Yahoo Finance
X4 days Vertex Wins An Early Approval; Why It Might Not Move Vertex’s Beleaguered Stock Investor's Business Daily
X5 days Ironwood Pharmaceuticals shares surge on competitor’s woes Investing.com
X5 days Rhythm Pharmaceuticals’ Obesity Treatments Target Less Crowded Space, Analyst Sees Long-Term Potential Yahoo Finance
X5 days Bristol-Myers Squibb: Rich Dividends & Double-Digits Upside Potential – Bright 2026 Prospects Seeking Alpha
X5 days Vanda Pharmaceuticals: Net-Net Status Presents A Trading Opportunity Seeking Alpha
X5 days VRTX Down as Non-Opioid Drug Shows Similar Pain Reduction as Placebo Zacks
X5 days Cramer’s Mad Dash: Vertex Pharmaceuticals YouTube
X5 days Ionis Gets FDA Approval for Rare Disease Drug Tryngolza Zacks
X5 days Is Vertex Stock A Sell After Pain Drug Whiffs In Midstage Study? Investor's Business Daily
X5 days Bristol-Myers Squibb Will Handle The Patent Cliff And Is Still Undervalued Seeking Alpha
X5 days Why Bristol Myers Squibb (BMY) Dipped More Than Broader Market Today Zacks
X5 days These Stocks Moved the Most Today: Micron, Tesla, Palantir, Quantum Computing, Lamb Weston, Accenture, Vertex, Darden, and More Yahoo Finance
X6 days Bristol Myers Squibb Stock Earns 83 RS Rating Investor's Business Daily
X6 days Vertex shares downgraded at Oppenheimer amid LSR trial uncertainties Investing.com
X6 days Stocks on the Move: Vertex Pharma, Shake Shack, Zoom, Lennar and Home Depot YouTube
X6 days Vertex Dives 11% On A ‘Worst-Case Scenario’ For Its Non-Opioid Pain Drug Investor's Business Daily
X6 days Cramer’s Stop Trading: Vertex Pharmaceuticals YouTube
X6 days Stocks to Watch Thursday: Micron, Robinhood, Vertex, Coinbase Yahoo Finance
X6 days Vertex shares tumble following Phase 2 pain study results Investing.com
X6 days Vertex Non-Opioid Drug Doesn’t Best Placebo In Back Pain Study. The Stock Is Plunging. Investor's Business Daily
X7 days Corvus Pharmaceuticals: Not Just A One-Hit Wonder In ITK Inhibitor Targeting Seeking Alpha
X7 days REGN’s Eylea HD Shows Non-Inferiority to Eylea in Eye Disease Study Zacks
X7 days Should Value Investors Buy ANI Pharmaceuticals (ANIP) Stock? Zacks
X7 days Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know Zacks
X7 days Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It Zacks
X7 days Bristol-Myers: Still An Opportunity Yielding Over 4% Seeking Alpha
X7 days SNY, TEVA Stocks Jump on Encouraging Data From IBD Drug Study Zacks
X7 days Corvus Pharmaceuticals stock rebounds on positive trial results Investing.com
X7 days Health AI startup Suki deliver patient summary, Q&A features for clinicians with Google Cloud CNBC
X1 week Stocks making the biggest moves midday: Pfizer, Broadcom, Teva Pharmaceuticals and more CNBC
X1 week NVS vs. LLY: Which Stock Should Value Investors Buy Now? Zacks
X1 week 4 Big Drug Stocks That May Continue to Outperform in 2025 Zacks
X1 week Novo Nordisk A/S (NVO) is Attracting Investor Attention: Here is What You Should Know Zacks
X1 week Why Vertex Pharmaceuticals (VRTX) Outpaced the Stock Market Today Zacks
X1 week Jefferies Upgrades Bristol Myers Squibb to ‘buy’ on drug Cobenfy Investing.com
X1 week BMY vs. VRTX: Which Stock Is the Better Value Option? Zacks
X1 week Tarsus Pharmaceuticals & SpringWorks Therapeutics: Jonathan Faison’s Top 2 Picks Seeking Alpha
X1 week Inovio Pharmaceuticals: The Dangerous Allure Of A Falling Knife Seeking Alpha
X2 weeks Bristol Myers Squibb (BMY) Stock Moves -0.89%: What You Should Know Zacks
X2 weeks Regeneron Down 15.5% Year to Date: How to Play the Stock? Zacks
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.